Why the study?
Does antithrombin III inhibit thrombin-stimulated proliferation in cultured human mesangial cells?
Does antithrombin III inhibit thrombin-stimulated proliferation in cultured human mesangial cells?
Antithrombin III effectively inhibits thrombin's mitogenic action on human mesangial cells, independent of heparin's antiproliferative effects.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for antithrombin III in mesangial proliferative diseases; leaves open translation from cell culture to clinical settings.
Thrombin stimulates and heparin and heparan sulfate inhibit mesangial cell proliferation. In addition, heparin has been shown to inhibit thrombin-stimulated smooth muscle cell proliferation. The anticoagulant action of heparin is mediated by antithrombin III. This study investigated whether heparin's antiproliferative action is also mediated by antithrombin III. To this end, the effect of antithrombin III on thrombin-stimulated mesangial cell growth was examined. As expected, thrombin stimulated DNA synthesis and cell growth in cultured human mesangial cells. The effect of thrombin on DNA synthesis and mesangial cell proliferation was inhibited by standard heparin and antithrombin III, separately or together. The magnitude of the inhibitory action of antithrombin III was equal to that of equimolar concentrations of heparin and that observed with the combination of the two. Experiments carried out in serum (hence antithrombin III)-free medium revealed that heparin's inhibitory effects are independent of antithrombin III. It was concluded that antithrombin III, an endogenous inhibitor of thrombin's coagulant activity, is an equally effective inhibitor of thrombin's mitogenic action.
No takes yet. Share an insight, caveat, or question.
Pahl et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: